| Literature DB >> 36105411 |
Nivedhitha Kabeerdass1, Selvankumar Thangaswamy2, Vaithilingam Mohanasrinivasan3, Chandrasekaran Rajasekaran3, Selvakumar Sundaram4, Thajuddin Nooruddin5, Maghimaa Mathanmohun1.
Abstract
Purpose of Review: This article provides the explanatory manuscript regarding the SARS-Corona virus 2. Sub-titled as the history of single-stranded RNA, internal characters of COVID-19, resource, the life cycle of COVID-19, reservoir of the disease, secondary infections of COVID-19 and nano herbal remedy. Recent Findings: The skin is not the main target of the SARS-corona virus 2 infections but somehow directly or indirectly, it causes exacerbating eruptions on the skin. Recent research shows that curcumin-mediated synthesized AgNPs show its potential character in the entry of respiratory syncytial virus (RSV), blocks interaction with the viral surface, and damages the viral protein. In modern days, molecular docking studies fabricated copper iodide flower extract (CuI-FE) which shows tough inhibitory action against COVID-19. Many articles show green synthesis-mediated nanoparticles like silver, gold, zinc, copper, iron, titanium dioxide, selenium, and cadmium which possess high anti-viricidal activity. Summary: The anti-oxidant, anti-viral, anti-inflammatory, anti-hive rich plant-mediated nanoparticle synthesis might be an alternative betterment, cost-effective, and eco-friendly medication for the skin disease caused by SARS-corona virus 2 (the viral clinical signs are itchy, hives, rashes, papules, psoriasis, and inflammation) and (non-viral clinical signs-pressure urticaria, contact dermatitis, and acne) that occurred as the result of COVID-19.Entities:
Keywords: Anti-hives; Coronavirus; Cuticular; Pandemic; Phytotherapeutic; Reservoir
Year: 2022 PMID: 36105411 PMCID: PMC9461414 DOI: 10.1007/s40495-022-00303-x
Source DB: PubMed Journal: Curr Pharmacol Rep ISSN: 2198-641X
Variants of SARS-CoV-2
| S. no | Alpha | Beta |
|---|---|---|
| 1 | Human coronavirus 229E (HCoV-229E) | HCoV-HKU1 (subgroup-A) |
| 2 | Humancorona virus (HCoV-NL63) | Human coronavirus OC43, SARS-CoV Severe acute respiratory syndrome coronavirus (subgroup-B) |
| 3 | - | Middle East respiratory syndrome-related coronavirus (MERS-CoV) (subgroup-C) |
Plant-mediated nanoparticles synthesize help in the viral skin problems. Different therapeutic plants and their three-dimensional structure, synthesized nanoparticles, size, shape, and characterization study show their efficacy on skin ailments are described in detail
Gram-positive and gram-negative bacteria, fungi, and algae-mediated nanoparticles are the precursors in the viral skin problem
| S. no | Bacteria | Fungi | Algae | NPs | Characterization study | Mechanical action | Reference |
|---|---|---|---|---|---|---|---|
| 1 | Ag, Au, and ZnO | SEM, TEM, and UV spectroscopy | Inhibit the spike protein | [ | |||
| 2 | Ag and Au | SEM and TEM | Inactivate the virus and block the virus entry | [ | |||
| 3 | Ag, and Au | SEM and TEM | Competition for the binding of the virus to the cell | [ | |||
| 4 | Ag | TEM,SEM | Interference with viral attachment | [ | |||
| 5 | Ag, and Au | SEM, TEM | Inactivate the virus and block the virus entry | [ | |||
| 6 | Tubinaria Conoides | Au, Ag, and Zn | TEM | Block the virus entry and penetration | [ | ||
| 7 | Ag and Au | TEM | Competition for the binding of the virus to the cell | [ | |||
| 8 | Ag and Au | SEM | Interaction with gp120 | [ | |||
| 9 | Ag | SEM | Inhibit the spike proteins | [ | |||
| 10 | Ag | TEM | Inhibit the virus-cell entry | [ |
Fig. 1Lifecycle of SARS-COV-2 and inhibition of skin infections by plant-mediated nanoparticles might act as an antiviral agent. (1) SARS-COV-2 virus. (2) ACE2 receptor (angiotensin-converting enzyme-2). (3) Pre inflammatory occurred due to ACE2 receptor. (4) Binding of the virus with ACE2 receptor. (5) mRNA synthesis of the viral genome. (6) Transcription and translation occur in the nucleus by the formation of virions in the endoplasmic reticulum, Golgi bodies, and mitochondria. (7) Assembly and budding of virions. (8) Exocytosis release of the mature viral progeny. (9) Plant-mediated metal nanoparticle (viral inhibitor). (10) Block the ACE2receptor and inhibit the virus entry by binding with the virus. (11) Block the transcription and translation, inhibit the formation of the virion in the cell organelles, and also inhibit the assembly of the virion. (12) Metal nanoparticles after playing the role of inhibitors and act as an anti-inflammatory agent. (13) Plant-mediated metal nanoparticles might act as an alternative medication in treating the skin infections caused by COVID-19